ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 41 filers reported holding ESSA PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $83,000 | -85.0% | 26,282 | -70.6% | 0.00% | -100.0% |
| Q1 2022 | $552,000 | -56.6% | 89,448 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $1,271,000 | +91.1% | 89,448 | +7.7% | 0.00% | +100.0% |
| Q3 2021 | $665,000 | -86.9% | 83,068 | -53.4% | 0.00% | -90.0% |
| Q2 2021 | $5,087,000 | +10.4% | 178,068 | +12.3% | 0.01% | 0.0% |
| Q1 2021 | $4,608,000 | +701.4% | 158,608 | +229.3% | 0.01% | +900.0% |
| Q4 2020 | $575,000 | +181.9% | 48,166 | +62.7% | 0.00% | 0.0% |
| Q3 2020 | $204,000 | – | 29,597 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |